SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined…

Entrada Therapeutics, Inc. · CLUSTER filed Sep 3, 2026 at 19:21 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Sep 3, 2026 at 19:21 ET

Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined $515K in open-market shares over a week, representing ~0.18% of market cap. The CEO had a non-cash tax withholding transaction. This selling is part of a broader 30-day trend of $1.8M in insider sales, but the amounts are modest and involve only large holders, not C-suite executives.

  • MPM BioVentures 2014 sold 29,088 shares at $7.06 ($205K) on 2026-09-01
  • MPM BioVentures 2018 sold 44,259 shares at $6.99 ($309K) on 2026-08-31
  • CEO Doshi Dipal had a tax withholding of 8,724 shares at $7.14 ($62K) on 2026-09-02 (non-cash)
  • Total insider selling over the past 30 days is $1.8M across 9 transactions

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access